{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:10:21Z","timestamp":1758579021280,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals USA Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.transproceed.2023.12.020","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:47:15Z","timestamp":1708217235000},"page":"394-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gaining Consensus Around Patient Risk Groups and Prognostic Profiles to Guide CMV Management Among Patients With Allogeneic Hematopoietic Stem Cell Transplant: Insights From a Delphi Panel With Hematopoietic Stem Cell Transplant Experts"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6240-8867","authenticated-orcid":false,"given":"Marlon","family":"Graf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rifat","family":"Tuly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priti","family":"Pednekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine","family":"Batt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2023.12.020_bib0001","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1182\/blood-2021-147499","article-title":"Outcomes of cytomegalovirus monitoring in autologous transplantation: a single institution experience","volume":"138","author":"Fesler","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0002","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/01.tp.0000521352.80415.b6","article-title":"Effect of a CMV risk stratification program at a single-center intestinal transplant institution","volume":"101","author":"Matsumoto","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0003","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0005","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbmt.2012.05.015","article-title":"Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation","volume":"18","author":"Green","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0006","unstructured":"Boeckh M. New insights into cytomegalovirus infection after allogeneic hematopoietic stem cell transplant. 2017;15:515\u20137."},{"key":"10.1016\/j.transproceed.2023.12.020_bib0007","doi-asserted-by":"crossref","unstructured":"Dziedzic M, Sadowska-Krawczenko I, Styczynski J. Risk factors for cytomegalovirus infection after allogeneic hematopoietic cell transplantation in malignancies: proposal for classification. 2017;37:6651\u20136.","DOI":"10.21873\/anticanres.12111"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0008","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/ajt.15515","article-title":"Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): a systematic review, meta-analysis, and meta-regression analysis","volume":"19","author":"Gimenez","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/imj.14462","article-title":"New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation","volume":"50","author":"Yong","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0010","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1038\/bmt.2008.120","article-title":"CMV infections after hematopoietic stem cell transplantation","volume":"42","author":"Ljungman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12874-016-0165-8","article-title":"Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology","volume":"16","author":"Eubank","year":"2016","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0012","doi-asserted-by":"crossref","first-page":"e16542","DOI":"10.1097\/MD.0000000000016542","article-title":"Real-world experience with pembrolizumab in patients with advanced melanoma: a large retrospective observational study","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0013","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12875-018-0831-5","article-title":"Protocol for a Delphi consensus exercise to identify a core set of criteria for selecting health related outcome measures (HROM) to be used in primary health care","volume":"19","author":"Santaguida","year":"2018","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2020.04.028","article-title":"Delphi consensus on core criteria set selecting among health-related outcome measures (HROM) in primary health care","volume":"127","author":"Santaguida","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","article-title":"Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies","volume":"67","author":"Diamond","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0016","doi-asserted-by":"crossref","first-page":"e20476","DOI":"10.1371\/journal.pone.0020476","article-title":"Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review","volume":"6","author":"Boulkedid","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135162","article-title":"Evaluation of nine consensus indices in Delphi foresight research and their dependency on Delphi survey characteristics: a simulation study and debate on Delphi design and interpretation","volume":"10","author":"Birko","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2023.12.020_bib0018","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3390\/ijms20112666","article-title":"Cytomegalovirus infections after hematopoietic stem cell transplantation: current status and future immunotherapy","volume":"20","author":"Cho","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:47:44Z","timestamp":1758577664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0041134524000770"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.12.020","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaining Consensus Around Patient Risk Groups and Prognostic Profiles to Guide CMV Management Among Patients With Allogeneic Hematopoietic Stem Cell Transplant: Insights From a Delphi Panel With Hematopoietic Stem Cell Transplant Experts","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}